RS50508B - Univerzalno primenljiva krvna plazma sa dezaktiviranim virusom proizvedena od delova plazme koji ne pripadaju beloj rasi - Google Patents
Univerzalno primenljiva krvna plazma sa dezaktiviranim virusom proizvedena od delova plazme koji ne pripadaju beloj rasiInfo
- Publication number
- RS50508B RS50508B RSP-2007/0211A RSP20070211A RS50508B RS 50508 B RS50508 B RS 50508B RS P20070211 A RSP20070211 A RS P20070211A RS 50508 B RS50508 B RS 50508B
- Authority
- RS
- Serbia
- Prior art keywords
- blood
- plasma
- parts
- caucasian
- universelely
- Prior art date
Links
- 210000002381 plasma Anatomy 0.000 title abstract 9
- 241000700605 Viruses Species 0.000 title 1
- 210000004369 blood Anatomy 0.000 abstract 10
- 239000008280 blood Substances 0.000 abstract 10
Classifications
-
- C—CHEMISTRY; METALLURGY
- C01—INORGANIC CHEMISTRY
- C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
- C01G23/00—Compounds of titanium
- C01G23/04—Oxides; Hydroxides
- C01G23/047—Titanium dioxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/14—Blood; Artificial blood
- A61K35/16—Blood plasma; Blood serum
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/29—Titanium; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
-
- B—PERFORMING OPERATIONS; TRANSPORTING
- B82—NANOTECHNOLOGY
- B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
- B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Veterinary Medicine (AREA)
- General Health & Medical Sciences (AREA)
- Hematology (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cell Biology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Inorganic Chemistry (AREA)
- Biomedical Technology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Virology (AREA)
- Zoology (AREA)
- Developmental Biology & Embryology (AREA)
- Biotechnology (AREA)
- Birds (AREA)
- Nanotechnology (AREA)
- Immunology (AREA)
- Geology (AREA)
- General Life Sciences & Earth Sciences (AREA)
- Manufacturing & Machinery (AREA)
- Environmental & Geological Engineering (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- External Artificial Organs (AREA)
Abstract
Krvna plazma, naznačena time, što služi za humanu upotrebu i dobijena je od davaoca koji pripadaju do 10% ili više populaciji koja nije bela rasa, plazma koja se može dobiti mešanjem krvi ili krvne plazme krvnih grupa A i B, opciono AB bez smešanja krvi ili krvne plazem krvne grupe O karakterisana sa- pet do šest delova krvi ili krvne plazme od davaoca koji imaju krvnu grupu A- četiri do pet delova krvi ili krvne plazme od davaoca koji imaju krvnu grupu B- nula do jedan deo krvi ili krvne plazme od davaoca koji imaju krvnu grupu AB.Prijava sadrži još 1 + 10 patentnih zahteva.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP03029359 | 2003-12-19 | ||
| PCT/EP2004/053608 WO2005058334A1 (en) | 2003-12-19 | 2004-12-20 | A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| RS50508B true RS50508B (sr) | 2010-03-02 |
Family
ID=34684548
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| RSP-2007/0211A RS50508B (sr) | 2003-12-19 | 2004-12-20 | Univerzalno primenljiva krvna plazma sa dezaktiviranim virusom proizvedena od delova plazme koji ne pripadaju beloj rasi |
Country Status (23)
| Country | Link |
|---|---|
| US (2) | US20070071829A1 (sr) |
| EP (1) | EP1696940B1 (sr) |
| JP (1) | JP2007514716A (sr) |
| KR (1) | KR101077976B1 (sr) |
| CN (1) | CN1893960B (sr) |
| AT (1) | ATE357242T1 (sr) |
| AU (1) | AU2004298790B2 (sr) |
| BR (1) | BRPI0417680A (sr) |
| CA (1) | CA2550060A1 (sr) |
| CY (1) | CY1106661T1 (sr) |
| DE (1) | DE602004005501T2 (sr) |
| DK (1) | DK1696940T3 (sr) |
| ES (1) | ES2281848T3 (sr) |
| IL (1) | IL175558A0 (sr) |
| NO (1) | NO20062360L (sr) |
| PL (1) | PL1696940T3 (sr) |
| PT (1) | PT1696940E (sr) |
| RS (1) | RS50508B (sr) |
| RU (1) | RU2362571C2 (sr) |
| SI (1) | SI1696940T1 (sr) |
| UA (1) | UA83528C2 (sr) |
| WO (1) | WO2005058334A1 (sr) |
| ZA (1) | ZA200604941B (sr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1958618A1 (de) | 2007-02-15 | 2008-08-20 | Octapharma AG | Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren |
| FR2963737B1 (fr) * | 2010-08-16 | 2013-04-05 | Etat Francais Ministere De La Defense Service De Sante Des Armees | Procede de lyophilisation de plasma sanguin |
| EP3093035A1 (en) | 2015-05-13 | 2016-11-16 | Sanofi-Aventis Deutschland GmbH | Injection device for delivery of a liquid medicament |
| CN107496453A (zh) * | 2017-08-13 | 2017-12-22 | 发贵科技（贵州）有限公司 | 一种有病毒灭活功能的血浆抗凝剂 |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4664913A (en) * | 1982-05-24 | 1987-05-12 | Xoma Corporation | Method for treating plasma for transfusion |
| US4764369A (en) * | 1983-07-14 | 1988-08-16 | New York Blood Center Inc. | Undenatured virus-free biologically active protein derivatives |
| US5217627A (en) * | 1990-11-06 | 1993-06-08 | Pall Corporation | System and method for processing biological fluid |
| AU667530B2 (en) * | 1992-05-28 | 1996-03-28 | New York Blood Center, Inc., The | Removal of antibodies from blood-derived compositions while retaining coagulation factors |
| EP0896824A1 (en) * | 1997-08-05 | 1999-02-17 | Octapharma Ag | A universally applicable blood plasma |
| CN1207004C (zh) * | 2001-04-18 | 2005-06-22 | 马建川 | 通用型冻干血浆及其制备方法 |
| US20030133829A1 (en) * | 2001-12-21 | 2003-07-17 | Baxter Healthcare Corporation | Process for inactivating pathogens in a biological material |
-
2004
- 2004-12-20 UA UAA200608016A patent/UA83528C2/uk unknown
- 2004-12-20 RS RSP-2007/0211A patent/RS50508B/sr unknown
- 2004-12-20 AT AT04804944T patent/ATE357242T1/de active
- 2004-12-20 CA CA002550060A patent/CA2550060A1/en not_active Abandoned
- 2004-12-20 PT PT04804944T patent/PT1696940E/pt unknown
- 2004-12-20 DE DE602004005501T patent/DE602004005501T2/de active Active
- 2004-12-20 CN CN2004800374273A patent/CN1893960B/zh not_active Expired - Fee Related
- 2004-12-20 US US10/580,548 patent/US20070071829A1/en not_active Abandoned
- 2004-12-20 ES ES04804944T patent/ES2281848T3/es active Active
- 2004-12-20 SI SI200430285T patent/SI1696940T1/sl unknown
- 2004-12-20 DK DK04804944T patent/DK1696940T3/da active
- 2004-12-20 WO PCT/EP2004/053608 patent/WO2005058334A1/en active Application Filing
- 2004-12-20 RU RU2006126055/15A patent/RU2362571C2/ru not_active IP Right Cessation
- 2004-12-20 BR BRPI0417680-4A patent/BRPI0417680A/pt not_active IP Right Cessation
- 2004-12-20 PL PL04804944T patent/PL1696940T3/pl unknown
- 2004-12-20 JP JP2006544462A patent/JP2007514716A/ja active Pending
- 2004-12-20 AU AU2004298790A patent/AU2004298790B2/en not_active Ceased
- 2004-12-20 KR KR1020067012074A patent/KR101077976B1/ko not_active IP Right Cessation
- 2004-12-20 EP EP04804944A patent/EP1696940B1/en active Active
-
2006
- 2006-05-11 IL IL175558A patent/IL175558A0/en not_active IP Right Cessation
- 2006-05-23 NO NO20062360A patent/NO20062360L/no not_active Application Discontinuation
- 2006-06-15 ZA ZA200604941A patent/ZA200604941B/en unknown
-
2007
- 2007-06-15 CY CY20071100800T patent/CY1106661T1/el unknown
-
2010
- 2010-08-24 US US12/805,920 patent/US20110104298A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| ATE357242T1 (de) | 2007-04-15 |
| RU2006126055A (ru) | 2008-01-27 |
| PT1696940E (pt) | 2007-05-31 |
| EP1696940B1 (en) | 2007-03-21 |
| CY1106661T1 (el) | 2012-05-23 |
| UA83528C2 (uk) | 2008-07-25 |
| NO20062360L (no) | 2006-05-23 |
| DK1696940T3 (da) | 2007-07-30 |
| WO2005058334A1 (en) | 2005-06-30 |
| RU2362571C2 (ru) | 2009-07-27 |
| ES2281848T3 (es) | 2007-10-01 |
| DE602004005501D1 (de) | 2007-05-03 |
| AU2004298790A1 (en) | 2005-06-30 |
| KR20060126662A (ko) | 2006-12-08 |
| SI1696940T1 (sl) | 2007-08-31 |
| ZA200604941B (en) | 2007-11-28 |
| US20070071829A1 (en) | 2007-03-29 |
| PL1696940T3 (pl) | 2007-08-31 |
| DE602004005501T2 (de) | 2007-11-29 |
| CN1893960B (zh) | 2012-10-31 |
| EP1696940A1 (en) | 2006-09-06 |
| CA2550060A1 (en) | 2005-06-30 |
| IL175558A0 (en) | 2006-09-05 |
| KR101077976B1 (ko) | 2011-10-28 |
| CN1893960A (zh) | 2007-01-10 |
| BRPI0417680A (pt) | 2007-03-20 |
| US20110104298A1 (en) | 2011-05-05 |
| JP2007514716A (ja) | 2007-06-07 |
| AU2004298790B2 (en) | 2010-04-08 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE602005012276D1 (de) | Verwendung von probiotischen bakterien zur herstellung von topischen zusammensetzungen zum schutz der haut | |
| CU20080010A7 (es) | Inhibidores macrocíclicos de la replicación del virus de la hepatitis c | |
| BRPI0511834A (pt) | métodos por tratar hepatite c | |
| RS50753B (sr) | Vakcina koja sadrži oslabljeni pestivirus | |
| DE502005002929D1 (de) | Orale darreichungsform enthaltend probiotische bakterien | |
| ATE495739T1 (de) | Pharmazeutische zusammensetzungen und verfahren zur verwendung von levodopa und carbidopa | |
| ECSP045382A (es) | Fenilacetamidas sustituidas y su uso como activadores de glucoquinasa | |
| BRPI0518187A (pt) | formulações de olanzapina em nanopartìcula injetáveis | |
| BR112016026273A8 (pt) | composição pesticida, e seu processo de aplicação | |
| CL2007002671A1 (es) | Compuestos derivados de octahidro-pirrolo[3,4-c]pirrol; composicion farmaceutica que la comprende; y uso del compuesto en el tratamiento del vih, sida o arc. | |
| DE602008002711D1 (de) | Kontrollierte freisetzung von aktiven aldehyden und ketonen aus ausgewogenen dynamischen mischungen | |
| ATE453328T1 (de) | Verbesserte formulierung zur bereitstellung eines magensaftresitenten beschichtungsmaterials | |
| RS50671B (sr) | Kristalisan polietilen tereftalat, koji sadrži silicijum, i postupak za njegovo dobijanje | |
| DE602005009681D1 (de) | Haarbehandlungszusammensetzungen mit einem disaccharid; einer disäure und einer ammoniumionen-quelle | |
| ATE439851T1 (de) | Verwendung probiotischer bakterien zur behandlung von infektionen | |
| RS50508B (sr) | Univerzalno primenljiva krvna plazma sa dezaktiviranim virusom proizvedena od delova plazme koji ne pripadaju beloj rasi | |
| ECSP077423A (es) | Coadministración de tigeciclina y digoxin | |
| ATE536925T1 (de) | Dekontaminierungsformulierungen | |
| FR2846327B1 (fr) | Derives de n-benzodioxolyl, n-benzodioxanyl et n-benzodioxepinyl arylcarboxamides utilisables dans le traitement de dyslipidemies et compositions pharmaceutiques les contenant. | |
| DE502005001365D1 (de) | Verwendung von Extrakten aus Wurzeln von Pelargonium sidoides und/oder Pelargonium Reniforme | |
| DE60322376D1 (de) | Sedative stoffe und behandlungen | |
| ATE468130T1 (de) | Inhibitoren der kostimulation via ox40 und deren verwendung gegen eine von virusen induzierten immunpathologie | |
| RS52118B (sr) | Postupak za dobijanje protozoalnih kultura i njihova primena | |
| DE602004013034D1 (de) | Pharmazeutische zusammensetzung beispielsweise zur verwendung als antivirales oder antibakterielles mittel und zur stimulierung von immunabwehr | |
| EA200900247A1 (ru) | Подкожные имплантаты, высвобождающие активный компонент в течение длительного времени |